Monika Raut

Center for Observational and Real-World Evidence (CORE)
Merck & Co., Inc.,

Merck & Co., Inc. (Employment)

Poster(s):

• (P-275) A Systematic Literature Review of the Epidemiology, Health-related Quality of Life and Economic Burden, Including Disease Pathways and Treatment Patterns of Relapsed/refractory Classical Hodgkin Lymphoma

• (P-276) Clinical Outcomes Among Relapsed/refractory (R/R) Adult and Pediatric Classical Hodgkin’s Lymphoma (cHL) Patients: A Global Systematic Literature Review (SLR)

• (P-277) An Updated Structured Review of the Epidemiology, Guidelines, and Real-world Treatment Patterns for Relapsed/refractory Primary Mediastinal Large B-cell Lymphoma